On-Demand Programs
Improving Breathing and Reducing Inflammation in Patients with Moderate-to-Severe Asthma Using Personalized Treatment Plans
This enduring activity is designed to enhance healthcare professionals’ understanding of the role of type 2 inflammation in asthma’s complex pathology and its impact on disease progression. Participants will review currently available biologic therapies that target type 2 inflammation and explore approaches for incorporating biologics therapies into individualized treatment plans.
RELEASED DATE: May 27, 2026
EXPIRATION DATE: May 27, 2027
Navigating the Complexities of Moderate-to-Severe Asthma from Diagnosis to Treatment Selection in Veteran Patients
Veterans face a unique and heightened burden from moderate-to-severe asthma, experiencing worsened morbidity and mortality due to the condition. This grand rounds enduring is designed to equip healthcare professionals in the VA setting with practical, evidence-based strategies to improve care for veteran patients with moderate-to-severe asthma. Through interactive, case-based learning, participants will enhance their understanding of type 2 inflammation, gain proficiency in the use of biologic therapies, and learn to individualize treatment plans to their veteran patients’ needs, all with the goal of improving outcomes for veteran patients with moderate-to-severe asthma.
RELEASED DATE: November 21, 2025
EXPIRATION DATE: November 21, 2026
Personalized Treatment to Improve Breathing and Reduce Inflammation in Patients with Moderate-to-Severe Asthma
This enduring activity is designed to enhance healthcare professionals’ understanding of the role of type 2 inflammation in asthma’s complex pathology and its impact on disease progression. Participants will explore evidence-based approaches for incorporating biologic therapies into individualized treatment plans and learn strategies for selecting the most appropriate biologic therapy based on patient-specific needs, preferences, and goals to optimize outcomes in moderate-to-severe asthma management. The program will also review GINA recommendations and when to incorporate biologic therapy.
RELEASED DATE: October 30, 2025
EXPIRATION DATE: October 30, 2026
Precision Treatment of the Underlying Inflammatory Endotype of Chronic Obstructive Pulmonary Disease
This enduring HoloModule activity is designed to provide healthcare professionals with evidence-based strategies to effectively diagnose, treat, and manage chronic obstructive pulmonary disease (COPD). It focuses on disease pathophysiology, inflammatory endotypes, and selection of biologic therapy with the goal of improving clinical outcomes. The program also reviews recommendations and updates from the latest GOLD Report.
RELEASED DATE: May 27, 2026
EXPIRATION DATE: May 27, 2027
Targeting the Underlying Inflammatory Endotype of Chronic Obstructive Pulmonary Disease
This enduring HoloModule activity is designed to provide healthcare professionals with evidence-based strategies to effectively diagnose, treat, and manage chronic obstructive pulmonary disease (COPD). It focuses on disease pathophysiology, inflammatory endotypes, and multidisciplinary, patient-centered care with the goal of improving clinical outcomes in managing COPD.
RELEASED DATE: October 30, 2025
EXPIRATION DATE: October 30, 2026
